secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2026-07-02T14:30:00+00:00
Accession:  0001213900-26-074678
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive Therapeutics reports preliminary Q2 2026 cash balance of $61.4M
-------------------------------------------------------------------------

- Ending cash balance of approximately $61.4 million as of June 30, 2026.
- Preliminary, unaudited results for the second quarter ended June 30, 2026.
- No other financial details or comparisons provided in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390026074678/0001213900-26-074678-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390026074678/ea0296892-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-074678

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer